Kiniksa Pharmaceuticals International, PLC (KNSA) — SC 13G Filings

All SC 13G filings from Kiniksa Pharmaceuticals International, PLC. Browse 4 Passive Stake Filing reports with AI-powered summaries and risk analysis.

SC 13G Filings (4)

SC 13G Filing — Nov 8, 2024
SC 13G Filing — Oct 21, 2024
Rubric Capital Discloses 2.9M Share Stake in Kiniksa Pharma — Feb 12, 2024 Risk: low
Rubric Capital Management LP, a Delaware-based investment firm, reported beneficial ownership of 2,907,501 Class A Common Shares of Kiniksa Pharmaceuticals, Ltd
BlackRock Discloses Significant Stake in Kiniksa Pharma — Jan 25, 2024
BlackRock, Inc., a major investment firm, reported its ownership in Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) as of December 31, 2023. This SC 13G filing ind

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX